Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Share-based Compensation (2024 - 2025)

Cannabis Bioscience International Holdings filings provide 2 years of Share-based Compensation readings, the most recent being $150000.0 for Q2 2025.

  • On a quarterly basis, Share-based Compensation rose 294.77% to $150000.0 in Q2 2025 year-over-year; TTM through Feb 2026 was $150000.0, a 38.89% increase, with the full-year FY2025 number at $220000.0, up 94.7% from a year prior.
  • Share-based Compensation reached $150000.0 in Q2 2025 per CBIH's latest filing, up from -$30000.0 in the prior quarter.
  • The five-year high for Share-based Compensation was $150000.0 in Q2 2025, with the low at -$30000.0 in Q4 2024.